INmune Bio
INMB
#8888
Rank
A$0.16 B
Marketcap
$7.29
Share price
3.41%
Change (1 day)
-54.12%
Change (1 year)

Earnings for INmune Bio (INMB)

Earnings in 2024 (TTM): -A$61.31 Million

According to INmune Bio's latest financial reports the company's current earnings are A$0.04 Million. In 2023 the company made an earning of -A$48.05 Million a decrease over its 2022 earnings that were of -A$43.72 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for INmune Bio from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$61.31 Million27.58%
2023 -A$48.05 Million9.92%
2022 -A$43.72 Million-10.02%
2021 -A$48.59 Million150.76%
2020 -A$19.38 Million57.58%
2019 -A$12.3 Million-38.28%
2018 -A$19.92 Million